<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="igfbp3_1s" dataset_id="pht001040.v5" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Insulin-like Growth Factor 1 (IGF-1) and Insulin-like Growth Factor Binding Protein 3 (IGFBP-3), Generation 3 Cohort Exam 1</description><variable id="phv00080763.v4.p11" var_name="shareid" calculated_type="string" reported_type="integer"><description>SHARe ID Number</description><total><subject_profile><sex><male>1863</male><female>2111</female></sex></subject_profile><stats><stat n="3974" nulls="0"/></stats></total></variable><variable id="phv00080763.v4.p11.c1" var_name="shareid" calculated_type="string" reported_type="integer"><description>SHARe ID Number</description><total><subject_profile><sex><male>1798</male><female>2035</female></sex></subject_profile><stats><stat n="3833" nulls="0"/></stats></total></variable><variable id="phv00080763.v4.p11.c2" var_name="shareid" calculated_type="string" reported_type="integer"><description>SHARe ID Number</description><total><subject_profile><sex><male>65</male><female>73</female></sex></subject_profile><stats><stat n="138" nulls="0"/></stats></total></variable><variable id="phv00080760.v4.p11" var_name="igf1" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor 1 (IGF-1)</description><comment>Cases which measured below the lowest detectable assay limit of 9.4 ng/ml were set to 9.00 ng/ml (n=10)</comment><total><subject_profile><sex><male>1861</male><female>2111</female></sex></subject_profile><stats><stat n="3972" nulls="2" mean="128.8" sd="42.61" median="123.7" min="9" max="460.2"/><example count="11">9.00</example><example count="4">103.30</example><example count="4">116.14</example><example count="4">97.60</example><example count="4">115.56</example><example count="3">96.68</example><example count="3">121.60</example><example count="3">115.51</example><example count="3">123.21</example><example count="3">102.23</example></stats></total></variable><variable id="phv00080760.v4.p11.c1" var_name="igf1" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor 1 (IGF-1)</description><comment>Cases which measured below the lowest detectable assay limit of 9.4 ng/ml were set to 9.00 ng/ml (n=10)</comment><total><subject_profile><sex><male>1796</male><female>2035</female></sex></subject_profile><stats><stat n="3831" nulls="2" mean="128.8" sd="42.62" median="123.7" min="9" max="460.2"/><example count="11">9.00</example><example count="4">116.14</example><example count="4">97.60</example><example count="4">115.56</example><example count="3">96.68</example><example count="3">121.60</example><example count="3">115.51</example><example count="3">123.21</example><example count="3">141.84</example><example count="3">130.22</example></stats></total></variable><variable id="phv00080760.v4.p11.c2" var_name="igf1" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor 1 (IGF-1)</description><comment>Cases which measured below the lowest detectable assay limit of 9.4 ng/ml were set to 9.00 ng/ml (n=10)</comment><total><subject_profile><sex><male>65</male><female>73</female></sex></subject_profile><stats><stat n="138" nulls="0" mean="128.4" sd="42.72" median="121.4" min="33.86" max="257.4"/><example count="1">104.70</example><example count="1">93.93</example><example count="1">112.17</example><example count="1">131.00</example><example count="1">140.69</example><example count="1">84.06</example><example count="1">182.70</example><example count="1">94.88</example><example count="1">98.92</example><example count="1">111.06</example></stats></total></variable><variable id="phv00080761.v4.p11" var_name="igfbp3" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor binding protein 3 (IGFBP-3)</description><comment>Cases which measured below the lowest detectable assay limit of 75.99 ng/ml were set to 75.00 ng/ml (n=3). Cases above measurable limit of 5000 ng/ml were set to 5001 ng/ml (n=319). The user should determine how to handle these cases.</comment><total><subject_profile><sex><male>1861</male><female>2111</female></sex></subject_profile><stats><stat n="3972" nulls="2" mean="3024" sd="1104" median="2923" min="75" max="5001"/><example count="312">5001.0</example><example count="4">2785.1</example><example count="3">2438.6</example><example count="3">3254.5</example><example count="3">1766.6</example><example count="3">2985.7</example><example count="3">2167.3</example><example count="3">2776.3</example><example count="3">2162.7</example><example count="3">2689.9</example></stats></total></variable><variable id="phv00080761.v4.p11.c1" var_name="igfbp3" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor binding protein 3 (IGFBP-3)</description><comment>Cases which measured below the lowest detectable assay limit of 75.99 ng/ml were set to 75.00 ng/ml (n=3). Cases above measurable limit of 5000 ng/ml were set to 5001 ng/ml (n=319). The user should determine how to handle these cases.</comment><total><subject_profile><sex><male>1796</male><female>2035</female></sex></subject_profile><stats><stat n="3831" nulls="2" mean="3030" sd="1103" median="2927" min="75" max="5001"/><example count="303">5001.0</example><example count="4">2785.1</example><example count="3">2438.6</example><example count="3">3254.5</example><example count="3">1766.6</example><example count="3">2985.7</example><example count="3">2167.3</example><example count="3">2776.3</example><example count="3">2162.7</example><example count="3">2689.9</example></stats></total></variable><variable id="phv00080761.v4.p11.c2" var_name="igfbp3" calculated_type="decimal" units="ng/ml" reported_type="decimal"><description>Insulin-like growth factor binding protein 3 (IGFBP-3)</description><comment>Cases which measured below the lowest detectable assay limit of 75.99 ng/ml were set to 75.00 ng/ml (n=3). Cases above measurable limit of 5000 ng/ml were set to 5001 ng/ml (n=319). The user should determine how to handle these cases.</comment><total><subject_profile><sex><male>65</male><female>73</female></sex></subject_profile><stats><stat n="138" nulls="0" mean="2855" sd="1134" median="2775" min="194.9" max="5001"/><example count="9">5001.0</example><example count="1">3509.9</example><example count="1">2033.6</example><example count="1">2461.5</example><example count="1">1806.4</example><example count="1">2606.5</example><example count="1">1602.3</example><example count="1">4441.8</example><example count="1">3070.3</example><example count="1">2160.1</example></stats></total></variable><variable id="phv00080762.v3.p11" var_name="idtype" calculated_type="enum_integer" reported_type="encoded"><description>Framingham Cohort Identifier</description><total><subject_profile><sex><male>1863</male><female>2111</female></sex></subject_profile><stats><stat n="3974" nulls="0" mean_count="3974" median_count="3974" min_count="3974" max_count="3974"/><enum code="3" count="3974">Generation 3 cohort</enum></stats></total></variable><variable id="phv00080762.v3.p11.c1" var_name="idtype" calculated_type="enum_integer" reported_type="encoded"><description>Framingham Cohort Identifier</description><total><subject_profile><sex><male>1798</male><female>2035</female></sex></subject_profile><stats><stat n="3833" nulls="0" mean_count="3833" median_count="3833" min_count="3833" max_count="3833"/><enum code="3" count="3833">Generation 3 cohort</enum></stats></total></variable><variable id="phv00080762.v3.p11.c2" var_name="idtype" calculated_type="enum_integer" reported_type="encoded"><description>Framingham Cohort Identifier</description><total><subject_profile><sex><male>65</male><female>73</female></sex></subject_profile><stats><stat n="138" nulls="0" mean_count="138" median_count="138" min_count="138" max_count="138"/><enum code="3" count="138">Generation 3 cohort</enum></stats></total></variable></data_table>
